Skip to content

Prevalence of BRCA1/2 variants in an Ovarian Cancer Cohort: outcomes from a Nationwide Testing Program.

Sep 2026 · European Journal of Human Genetics · 0 citations · 34 references
Medicine

TL;DR

It is demonstrated that mainstreamed germline and somatic BRCA1/2 testing is feasible in Ireland and reports the prevalence of BRCA CAVs in a cohort of patients with OC, which is consistent with UK real-world data.

View source

Similar papers

Sep 2026

Real-World Landscape of BRCA Deleterious Alterations in Advanced Prostate Cancer: Insights From a Nationwide Genomic Database.

BACKGROUND The clinical characteristics of BRCA1 and BRCA2 (BRCA) deleterious alterations in advanced prostate cancer-considering age, family history, co-occurring gene alterations, and variant type-remain incompletely understood in patients undergoing tumor-only panel testing. MATERIALS AND METHODS We analyzed 2,815...

H. Tsumura, Dai Koguchi, K. Tabata et al. · 0 citations
Review Open access Sep 2026

Liquid biopsy: a new window on the BRCA genes

Beyond the attractive potential to surrogate the tumor tissue testing, to overcome the cancer spatial and temporal heterogeneity, and to monitor the tumor mutational profile over time, accurately detecting all clinically relevant BRCA genetic variants and epigenetic modifications using LB remains technically challengin...

L. Incorvaia, V. Gristina, F. Pepe et al. · 0 citations
Open access Sep 2026

Beyond Exons 19 and 21: mapping the clinical and molecular diversity of uncommon EGFR mutations in a Brazilian NSCLC cohort.

BACKGROUND Uncommon and complex EGFR variants respond variably to tyrosine kinase inhibitors, and data on their frequency in Brazil are scarce. METHODS We retrospectively analysed 141 patients with EGFR-mutated lung adenocarcinoma at a single Northeastern Brazilian centre. All profiling used treatment-naive diagnosti...

J. C. de Sousa, Cleto Nogueira, Guilherme de Sousa Veloso et al. · 0 citations
Open access Aug 2026

Prevalence and clinical impact of PIK3CA and PTEN alterations from reflex genomic testing of newly diagnosed colorectal cancer: a population-based series

The findings support implementing testing for use of a safe, inexpensive repurposed drug and underscore the importance of upfront testing for timely treatment decision-making and implementation of trial findings into routine practice.

L. Kerrin, Osamah Al Haddad, Ellen Reid et al. · 0 citations
Review Aug 2026

Dual germline BRCA and mismatch-repair mutations: a narrative review.

INTRODUCTION Multilocus inherited neoplasia alleles syndrome (MINAS) can pair a germline pathogenic BRCA1/2 variant with a pathogenic mismatch-repair (MMR) variant, but current guidelines manage the two inherited pathways separately. AREAS COVERED We searched PubMed, Embase, the American Society of Clinical Oncology...

Rui Chen, Chuang Ge, F. Yuan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.